Contents
3Modes of Narration: Evidence-Based Medicine and Knowledge Translation
4Narrative Framing of Puberty Blocker Research in Transgender Youth Healthcare
4.1The Cass Review: Independent Review of Gender Identity Services for Children and Young People
4.2Conflicting Narratives of Scientific Evidence: RCTs, Systematic Reviews, and Guidelines
4.3Narrating Transgender Youths: Competence and Gender Identity
4.4Narratives of Lived Experience: Amplified and Silenced Protagonists
5Narratives of (Ab)normality: IVF and Mosaic Embryos
5.1Chromosomal Mosaicism in IVF: From FISH to NGS and a New Paradigm of Embryo Selection
5.2PGDIS: Championing a Precision Toolkit for Embryo Selection
5.4ASRM’s Evolving Opinions (2018–2023) on PGT-A and Mosaic Embryos
5.6Proponents’ Narrative: Precision, Progress, and the Promise of Control
5.7Critics’ Narrative: Caution in Evidence-Based Medicine, Risk Frames, and Ethical Concerns
6Contested Evidence and Narrative Authority in the WHO’s 2022 Abortion Care Guideline
6.2Narrators and Narrative Authority: The Voice of the WHO versus Its Critics
6.3Protagonists, Antagonists, and the Distribution of Agency
6.4Patterns of Selective Appropriation: Evidence, Values, and Omissions
6.5Temporality and Emplotment: Stories of Progress and Decline
6.6Conclusions: Narrative Power and the Politics of Abortion Care